Research now shows that mutations in the BRCA2 gene instead of the BRCA1 produce tumors that have a better response to immunotherapy.
Using Radioactive Particles to Kill Cells Attached to a ‘Homing Device’ to Seek Out Cancers
Testing for genetic weaknesses in repairing DNA could pick out men who may benefit from a new type of targeted nuclear medicine, a new study reports.
An emerging class of drugs are made up of a radioactive particle that can kill cells attached to a ‘homing device’ to seek out cancers by detecting the presence of a target molecule on their surface.